ABT-450’s 30% value share of ABBV/ENTA’s 3-DAA regimen is disappointing; my valuation model in #msg-94993406 assumed 35%, so an adjustment to the model is needed.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.